Trial Profile
A Prospective Non-interventional Study (Nis) Of The Routine Use Of Etanercept In The Long-term Treatment Of Patients With Plaque-type Psoriasis In Everyday Practice: An Efficacy, Safety, And Health Economic Evaluation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2017
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Pfizer
- 31 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Jan 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.